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Autonomic Dysfunction in Diabetes
Early Progression of the Autonomic Dysfunction Observed
in Pediatric Type 1 Diabetes Mellitus
Daniela Lucini, Gianvincenzo Zuccotti, Mara Malacarne, Andrea Scaramuzza, Sara Riboni,
Carlo Palombo, Massimo Pagani
Abstract—To focus on early cardiac and vascular autonomic dysfunction that might complicate type 1 diabetes mellitus
in children, we planned an observational, cross-sectional study in a population of 93 young patients, under insulin
treatment, subdivided in 2 age subgroups (children: 11.50.4 years; adolescents: 19.30.2 years). Time and frequency
domain analysis of RR interval and systolic arterial pressure variability provided quantitative indices of the
sympatho-vagal balance regulating the heart period, of the gain of cardiac baroreflex, and of the sympathetic vasomotor
control. Sixty-eight children of comparable age served as a reference group. At rest, systolic arterial pressure and the
power of its low-frequency component were greater in patients than in controls, particularly in children (14.02.3
versus 3.10.3 mm Hg2). Moreover, baroreflex gain was significantly reduced in both subgroups of patients. Standing
induced similar changes in the autonomic profiles of controls and patients. A repeat study after 1 year showed a
progression in low-frequency oscillations of arterial pressure and a shift toward low frequency in RR variability. Data
in young patients with type 1 diabetes mellitus show a significant increase in arterial pressure, a reduced gain of the
baroreflex regulation of the heart period, and an increase of the low-frequency component of systolic arterial pressure
variability, suggestive of simultaneous impairment of vagal cardiac control and increases of sympathetic vasomotor
regulation. A repeat study after 1 year shows a further increase of sympathetic cardiac and vascular modulation,
suggesting early progression of the autonomic dysfunction. (Hypertension. 2009;54:987-994.)
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Cardiovascular autonomic neuropathy is a severe, fre-quently underrecognized complication of diabetes mel-
litus, of which the presence approximately doubles the
all-cause mortality risk.1 Traditionally, clinical markers of
diabetic cardiovascular autonomic neuropathy are based on a
battery of tests2 requiring the active collaboration of patients;
however, new methods have been described to assess the
integrity of autonomic function, such as spectral analysis of
RR interval variability3,4 or baroreflex sensitivity (BRS)5,6,
that can be obtained automatically from computer analysis of
noninvasive ECG and arterial pressure wave recordings, without
needing the active participation of patients. These latter methods
have been considered more sensitive7 than traditional tests and,
thus, could be particularly suited to assess initial changes in
autonomic performance, particularly in young patients affected
by type 1 diabetes mellitus (T1DM).
In adults, available data suggest that, with time, cardiovas-
cular autonomic neuropathy8 becomes characterized by re-
duced vagal control of the sinoatrial node, as expressed by
reduced RR variance and baroreflex gain, together with
impaired vascular regulation, as exemplified by reduced
orthostatic tolerance (as a consequence of standing induced
hypotension).1 Recently, an increase in the low-frequency
(LF) power of systolic (S) AP variability has also been
reported, in addition to BRS impairment in young adults
affected by T1DM.9
Given the relatively abrupt beginning of the disease, we
reasoned that children with T1DM might represent a unique
window on initial, preclinical autonomic disturbances and
harbor the potential to furnish suggestions on possible mech-
anisms. These are likely to be multifactorial and to an extent
reversible9 and assessable well before any anatomic (mal)ad-
aptation has taken place.
Thus, we planned the following observational study in a
population of children and adolescents affected by T1DM, all
under insulin treatment, to assess initial changes in cardiac
and vascular autonomic regulation and their early progression
over time by repeating observations in patients after 1 year.
Children with T1DM show early and progressive alterations
in indices of cardiac vagal regulation that are reduced and
indices of sympathetic cardiovascular markers that are
increased.
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Methods
Patient Selection
This study involved 93 consecutive young subjects affected by
T1DM (mean overall age: 15.60.4 years; 54 boys; 39 girls; body
mass index [BMI]: 21.40.6) who referred to our institutional
diabetic pediatric clinic for management. Insulin treatment was
optimized according to clinical evaluation. In all of the patients, the
presence of concomitant diseases (other than diabetes mellitus),
pharmacological treatment (other than insulin), or cigarette smoking,
alcohol, or food abuse was excluded by standard medical examina-
tion, inclusive of a neurological examination, and usual clinical tests.
A group of 68 additional healthy children and adolescents (mean
age: 15.90.6 years; 44 boys; 66 girls; BMI: 20.10.6) provided
control values. Thirty-two T1DM patients (age: 14.60.7 years)
were assessed a second time after 36618 days to glean time-
dependent dynamics of autonomic dysfunction.
The protocol of the study followed the principles of the Declara-
tion of Helsinki and Title 45, US Code of Federal Regulations, Part
46, Protection of Human Subjects (revised November 13, 2001,
effective December 13, 2001) and was approved by the institutional
ethics committee. All of the patients gave their informed consent to
participate.
Autonomic Evaluation
The day of the study, all of the subjects arrived at the laboratory 2
hours after a light breakfast, avoiding caffeinated beverages and
heavy physical exercise in the preceding 24 hours. Recordings were
always performed between 10:00 AM and 12:00 PM to account for
circadian variations.
After a preliminary 10-minute rest period in a supine position,
allowing for stabilization, blood pressure waveforms, ECG, and
respiratory activity were continuously recorded over a 10-minute
baseline and over a subsequent 7-minute period of active standing.
The ECG (CM5) and the respiratory signal were recorded in all of
the subjects with a 2-way radiotelemetry system (Marazza), whereas
AP waveform was continuously assessed noninvasively by a Fi-
napres device (Finapres, Ohmeda), the accuracy of which, in
tracking beat-by-beat blood pressure changes, has been documented
previously.10 Data were acquired with a personal computer using an
acquisition rate of 250 samples per channel per second.
As described previously,11,12 from the simultaneous autoregres-
sive spectral analysis of the RR interval and SAP variability, a series
of indices indirectly reflecting autonomic cardiovascular modulation
were derived. The power of RR interval spectral oscillations was
quantified considering, respectively, the component in the LF (0.03
to 0.14 Hz) and in the high-frequency (HF; 0.15 to 0.35 Hz) regions.
The power of LF spectral components was normalized according to
the formula PLF[(PLF[ms]2)/(VARRR[ms]2VLF[ms]2)]*100, where
PLF indicates LF powers in normalized units (nu), VAR indicates
total variance, and VLF indicates very LF component (0.03 Hz).
Similar normalization was performed for HF components. LF/HF of
the RR interval variability power ratio was also computed. Within
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Figure 1. Left, Example of the spectral profiles of a control subject (top) and a T1DM patient (bottom), for both RR interval variability
(top tracings) and SAP variability (SAP; bottom tracings). Note the greater amplitude of the LF component of SAP variability (LFSAP).
The center frequency of LFSAP is also slightly lower in T1DM patients (0.0810.002 Hz) vs controls (0.0900.002 Hz; P0.05; pow-
er0.5). Right, Example of the bispectral analysis of the same signals: coherence functions between RR variability and SAP variability
are represented with heavy lines and clearly indicate elevated values (0.5) in the correspondence of both the LF and HF components.
The observed LF center frequency is lower (P0.01; power0.78) in the case of the diabetic group vs controls. The phase functions
(dotted lines) are also presented for completeness and show a similar upsloping trend in both diabetics and controls.
988 Hypertension November 2009
 at UniversitÃ  degli Studi di Milano on August 6, 2013http://hyper.ahajournals.org/Downloaded from 
the sympathovagal model, the balance between LF and HF compo-
nents of RR variability (particularly using nu) reflects the changing
dynamics of, respectively, sympathetic and vagal oscillatory modu-
lation of the SA node. The power of SAP spectral oscillations was
also quantified considering the component in the LF region (0.33 to
0.14 Hz) in absolute units,12 as an index of sympathetic arterial blood
pressure modulation.
The sensitivity of arterial baroreflex control of the RR interval was
assessed by a frequency domain method ( index: average of the
square root of the ratio between the RR interval and SAP Spectral
powers in the LF and HF regions),6 and with a time domain method
(baroreflex slope).5 Baroreflex gain reflects tonic vagal cardiac
regulation.
In all of the subjects included in the study, respiratory rate
coincided with the HF component of RR variability. Bivariate
spectral analysis was used to verify that the squared coherence value
between RR and SAP variabilities at the LF and HF frequencies
always exceeded 0.5 (Figure 1).
Statistics
Data are presented in the text, figures, and tables as averageSEM.
Controls and T1DM patients were both divided in 2 subgroups by
median split of age and labeled as children and adolescents. This
label was nominally maintained for simplicity even if the latter
subgroup contained 8% of subjects 20 years of age, who had been
enrolled and treated in the pediatric outpatient clinic since the
inception of T1DM. Statistical evaluation included t test, Mann–
Whitney, and one-way ANOVA, followed by Tukey contrasts,
simple and multiple correlation, 2 test, and discriminant analysis, as
appropriate. Computations were performed with a commercial sta-
tistical package considering observed  levels of 0.05 and  levels
of 0.8 (SPSS version 17.0, SPSS, Inc).
Results
Table 1 shows average values for examined children and
adolescents (respectively, 11 and 20 years of age) in both
the T1DM and control groups. It is apparent that BMI and AP
are more elevated in subjects with T1DM, in both age classes,
with a differential in AP between patients and controls of
10 mm Hg in the adolescent group. In our study, only
T1DM patients underwent blood drawing for ethical and
organizational reasons, and, thus, creatinine and glycosylated
hemoglobin values are provided only for patients in Table 1,
with the latter ones being somewhat suboptimal in spite of
intensive treatment. Signs of clinical diabetic autonomic
neuropathy were absent, in particular, upon standing there
were no signs of orthostatic intolerance, although a slightly
significant drop in SAP was observed in subjects with T1DM.
Autonomic Analysis
As shown in Figure 1, spectral analysis of RR and SAP
variability showed in both patients and controls the presence
of LF and HF components, with a high coherence between
corresponding oscillations. RR variance was similar in all of
the subgroups (Table 2), whereas LF and HF oscillations in
absolute values tended to be greater in controls, and LF in nu
was more elevated in diabetic adolescents than in controls. In
T1DM patients, notably, the power of LFSAP was greater than
in controls, particularly in the children subgroup (see Figure
2, bottom). Conversely, baroreflex gain was significantly
reduced (Figure 2, top) in both age subgroups.
Effects of Standing Up
Table 3 shows changes in hemodynamic and autonomic
variables induced by active standing. As expected, the ma-
jority of indices of RR and SAP variability followed a pattern
of sympathetic activation and vagal withdrawal. This was
characterized essentially, like in adults, by a reduction of the
RR interval, an increase in LF RR (nu; and concomitant
reduction of HF), and a diminution of the  index (as well as
of BRS). These changes were similar in subjects with T1DM
Table 1. Descriptive Statistics of Patients and Controls,
Subdivided According to Age, Split Into Children and
Adolescents
Variable
Children Adolescents
Controls Diabetes 1 Controls T1DM
n 32 46 36 47
Age, y 11.20.5 11.50.4 20.20.3† 19.30.2†
Sex, male/female, % 47/53 67/33 39/61 49/51
BMI, kg/m2 15.91.6 19.30.4* 21.60.3† 23.60.5*†
SAP, mm Hg 104.02.2 111.42.1* 111.71.6 122.21.8*†
DAP, mm Hg 61.81.4 60.71.0 63.81.9 67.51.0†
HR, bpm 72.51.6 71.91.7 66.71.9 63.51.8†
Diabetes duration,
mo
NA 616 NA 1279†
Creatinine, mg/dL NA 0.560.02 NA 0.740.02
AER, mg/24 h NA 22.36.5 NA 10.72.2
Hb1Ac, % NA 8.20.2 NA 8.30.1
DAP indicates diastolic arterial pressure; HR, heart rate; AER, albumin
excretion rate; NA, not applicable. Significance tested with 1-way ANOVA,
followed by Tukey contrast, is indicated (2 test used for sex).
*Data were significantly different from the control group.
†Data were significantly different from the children group (P0.05).
Table 2. Descriptive Statistics of Autonomic Variables in
Patients and Controls, Subdivided According to Age, Split Into
Children and Adolescents
Variable
Children Adolescents
Controls T1DM Controls T1DM
RR, ms 83918 85318 92224 97126†
VARRR, ms
2 71221192 5866680 4551612 3856482
LFRR, ms
2 2418488 1491225 982137† 1049133
LFRR, nu 45.92.5 35.62.8 38.13.2 46.82.8†
HFRR, ms
2 2662482 2957443 2056434 1468269†
HFRR, nu 47.52.7 57.02.7 56.73.2 48.62.8
LF/HFRR 1.20.2 1.10.3 1.10.2 1.70.3
SAP, mm Hg 1033 1133 1082 1284*†
VARSAP, mm Hg 299 5710 295 427
LFSAP, mm Hg 3.10.3 14.02.3* 3.60.8 8.91.3
HFSAP, mm Hg 2.00.2 3.90.5 1.60.2 2.90.5
Respiratory
frequency, Hz
0.300.01 0.270.01 0.260.01 0.280.01
 index,
ms/mm Hg
343 201* 272 181*
BRS, ms/mm Hg 324 182* 313 172*
RR indicates RR interval; VAR, variance; LF, LF component; HF, HF
component; LF/HF, ratio between LF and HF components; SAP, SAP from
Finapres. Significance was tested with 1-way ANOVA, followed by Tukey
contrasts (2 test used for sex).
*Data were significantly different from control group.
†Data were significantly different from the children group (P0.05).
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and in controls. The only notable difference was a small, yet
significant, standing-induced reduction in SAP in patients,
more apparent in adolescents, that was never accompanied by
signs of orthostatic intolerance.
Correlations
Table 4 shows a matrix of simple correlations between major
autonomic variables and clinical indicators. It is apparent that
baroreflex gain and LF oscillations of AP are independent
from disease indicators, such as duration of disease, or
creatinine or glycosylated hemoglobin values (similar results
apply specifically to the children subgroup). RR-related
variables (in particular, LFRR in nu), also independent from
glycosylated hemoglobin, correlate with creatinine (except
for HFRR) and disease duration. Age appears instead corre-
lated with SAP and RR and inversely with  index. Plasma
creatinine is related to disease duration. In addition, BRS
essentially replicates results obtained with the  index (data
not shown).
Stepwise regression analysis confirmed the importance of
age and the lack of significant influence of metabolic param-
eters on major autonomic indices (significant models: age
versus RR total power; disease duration and SAP versus both
RR LF and HF in nu). Discriminant analysis, which is used
primarily to predict membership in 2 mutually exclusive
groups, was also performed here simply to assess the inte-
grated capacity of hemodynamic and autonomic variables to
discriminate between controls and T1DM patients. Notably,
the use of all of the available information produced a
percentage recognition (80%) that was only slightly supe-
rior to what could be obtained (70%) with only 3 significant
variables: SAP,  index, and LFSAP.
Figure 2. Top, Differences in a frequency domain
index of baroreflex gain ( index) in children
(YOUNG) and adolescent (OLD) subgroups,
according to the presence or absence
(CONTROLS) of T1DM (DIABETES 1). Notice the
significantly smaller baroreflex gain in both chil-
dren and adolescents affected by diabetes. Bot-
tom, Differences in a frequency domain index of
sympathetic vasomotor regulation in children
(YOUNG) and adolescent (OLD) subgroups,
according to the presence or absence
(CONTROLS) of T1DM (DIABETES 1). Notice the
greater power of LFSAP in diabetic children.
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Repeat Studies
In 32 patients with T1DM, a repeat study was performed 1
year after the first study to assess early progression of
autonomic dysfunction. Essential findings are shown in
Figure 3: a small significant increase in heart rate should be
contrasted with a clear shift of RR variability spectral compo-
nents toward a sympathetic profile (increase of LFnu and
decrease of HFnu), combined with a small nonsignificant reduc-
tion in baroreflex gain and a marked further rise in LFSAP.
Discussion
The novel findings of this investigation are that T1DM is
associated with marked alterations of indirect autonomic
indices, such as a reduced baroreflex gain and an increase in
slow frequency oscillations of SAP already in a pediatric
population. Furthermore, longitudinal observations under-
score the progressive nature of these autonomic alterations
that also regard the balance11 between LF and HF oscillations
of RR variability.
Clinically, the present study addresses pediatric T1DM in a
relative wide age range to better examine the influence of
length of the disease. Disease duration appeared correlated
with creatinine levels, yet within the normal range, poten-
tially also reflecting its link with patient age and BMI
(P0.001); disease duration was not, however, correlated
with vascular autonomic alterations (or albumin excretion
rate), but was linked to autonomic indices of cardiac LF and
HF balance. The short duration of the disease in our pediatric
population may also be reflected in the lack of signs of
clinical complications, such as a very small RR variance or
orthostatic hypotension. Indeed, in our patient group there
was a slightly smaller RR variance and a relatively clear,
although limited, drop in SAP on standing.
Autonomic analysis at baseline disclosed a clear reduction
in baroreflex gain in children and adolescents affected by
T1DM, considering both time domain and frequency domain
indices, extending recent observations in adults to this
younger age.9 This suggests that the impairment of the
cardiac baroreflex might represent a sensitive, early quanti-
tative indicator of diabetic autonomic impairment of the
cardiac vagal regulation in children as well. Baroreflex gain is
also selectively reduced in older patients affected by distur-
bances of glycemic metabolism, such as the metabolic syn-
drome,13 or in patients with type 2 diabetes mellitus14 and
their offspring.15 In this study, the repeat observations after 1
year suggest that the reduction in baroreflex gain is also
accompanied by signs of progressive increase of sympathetic
modulation to AP and of the autonomic balance to the
sinoatrial node. A similar combination has been reported in
prehypertensive adults16 and children,17 confirming that pe-
diatric diabetes mellitus might represent an early window on
altered cardiovascular autonomic control.
Considering that exogenous insulin increases efferent sym-
pathetic activity18 and provokes a shift of the balance between
LF and HF components of RR variability toward LF,19 we
might hypothesize a mechanistic role for therapeutic insulin
in the observed alterations in autonomic indices, in addition
to the possible direct effects of endothelial dysfunction,20,21
oxidative stress,22,23 Rho/Rho-kinase pathway,24 arginase
mechanisms,20 and adhesion molecules in initiating
sympatho-sympathetic positive feedback reflexes25 from the
arterial sites and thereby reducing baroreflex gain. As a
Table 3. Stand Induced Changes in Autonomic Variables in Patients and Controls, Subdivided
According to Age, Split Into Children and Adolescents
Variable
Children Adolescents
Controls T1DM Controls T1DM
RR, ms 16313* 20514* 19518* 24518*
VARRR, ms
2 40461131* 3628578* 1583637* 807501†
LFRR, ms
2 1136490* 174213 690226*† 679226*
LFRR, nu 30.93.1* 43.03.0* 40.42.9* 38.83.5*
HFRR, ms
2 2186456* 2681433* 1743412* 1239268*†
HFRR, nu 30.33.1* 40.92.8* 39.12.6* 37.83.4*
LF/HFRR 13.56.3* 12.82.9* 11.32.6* 17.72.8*
SAP, mm Hg 2.02.7 7.53.0* 2.44.5 11.34.2*
VARSAP, mm Hg
2 6.69.7 20.511.0 29.78.1* 39.312.9*
LFSAP, mm Hg
2 9.03.7* 22.97.0* 20.83.7* 29.17.0*
HFSAP, mm Hg
2 1.00.5 3.01.0* 3.80.9* 3.30.8*
Respiratory frequency, Hz 0.030.02 0.100.05 0.030.03 0.070.04
 index, ms/mm Hg 183* 131* 172* 111*
BRS, ms/mm Hg 15.94.4* 10.21.8* 20.22.8* 10.31.8*
RR indicates RR interval; VAR, variance; LF, LF component; HF, HF component; LF/HF, ratio between LF and HF
components; SAP, SAP from Finapres; BRS, baroreflex slope. Significance was tested with 1-way ANOVA, followed
by Tukey contrasts (2 test used for sex). Note that data represent averageSEM changes (standingresting) of
values computed individually (subject by subject), both for absolute and relative indices (in nu or LF/HF).
*Data show the significant difference between rest and standing.
†Data were significantly different from the children group (P0.05).
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corollary, the lack of relationship between glycosylated
hemoglobin and other parameters suggests that this index
might be a less sensitive indicator of diabetic complications
affecting cardiovascular regulatory mechanisms, in particu-
lar, changes in heart rate variability and blood pressure
variability. A clinical advantage of this approach might be
that indirect autonomic monitoring could furnish a surrogate
outcome to assess not only early cardiovascular damage but
also the beneficial effects of therapy, such as provided by
respiratory and exercise training,26 on autonomic dysregula-
tion or therapies targeting more directly endothelial func-
tion,27 such as with angiotensin-converting enzyme inhibi-
tors. An additional clinical observation regards the significant
increase in SAP observed in these young T1DM patients,
particularly apparent in the adolescent subgroup. Considering
that in adults even small increases in AP carry an adverse
prognosis28 and that diabetes mellitus has a supra-additive
effect with regard to cardiovascular risk, this finding might
suggest a more stringent focus on blood pressure control,
even at an earlier age. The critical role of cardiovascular
dysregulation in early T1DM can also be gleaned by the
observation that controls can clearly be discriminated from
patients by the simple information carried by autonomic
variables; indeed, only 3 of these indicators (ie, baroreflex
gain, AP, and LFSAP) are capable of providing a discrimina-
tive power of 70%. Future studies should address whether
initial alterations in metabolism or in vascular function (such
as an increase of intima-media thickness or an impaired
endothelium-dependent relaxation29) might play a mechanis-
tic role in the observed alterations in autonomic indices.
Limitations must also be stressed. This is an observational
study that considers a wide age range, thus providing data for
both children and adolescents. The longitudinal observation,
although limited in time, clearly showed a worsening in
autonomic indices within just 1 year. However, longer obser-
vation time might lead to more apparent worsening of
autonomic indices as shown, for example, by Ko et al30 in
type 2 diabetes mellitus patients. Autonomic dysregulation
was not assessed directly, although we used a battery of
several indirect indicators of both cardiac and vascular
autonomic regulation. We used both monovariate and biva-
riate indices and used a modern software tool31 based on
autoregressive algorithms that requires a minimum of opera-
tor interaction. Metabolic control was not optimal, in spite of
the use in several of these children of an insulin pump.
Perspectives
We have also shown that children and adolescents affected by
T1DM show marked autonomic alterations, characterized by
a significant increase in AP, a reduced gain of the baroreflex
regulation of the SA node, a progressive increase of LFSAP, a
shift of the balance between LF and HF RR oscillations
toward LF, suggestive of a simultaneous impairment of vagal
cardiac control and increases of sympathetic cardiovascular
regulation, possibly linked to insulin treatment. Given the
well-known beneficial effects of exercise training32 on these
disturbances in adults affected by important cardiovascular
disease, such as hypertension, coronary artery disease, and
congestive heart failure, it may be hypothesized that, also in
children with T1DM, exercise, eventually combined with
other functional treatments, such as deep breathing33,34 or
Table 4. Nonparametric Correlation Between Major Autonomic Variables and Disease Severity Indicators
Variable  Index SAP LFSAP RR LFRR HFRR HbA1c Creatinine Disease Duration Age
 index 1.000
SAP 0.471* 1.000
0.000*
LFSAP 0.463* 0.276* 1.000
0.000* 0.000*
RR 0.335* 0.115 0.119 1.000
0.000* 0.146 0.131
LFRR 0.275* 0.157* 0.139 0.145 1.000
0.000* 0.047* 0.078 0.067
HFRR 0.293* 0.135 0.142 0.220* 0.967* 1.00
0.000* 0.089 0.073 0.005* 0.000*
HbA1c 0.065 0.092 0.129 0.088 0.036 0.017 1.000
0.558 0.408 0.241 0.426 0.744 0.881
Creatinine 0.168 0.502* 0.076 0.502* 0.284* 0.170 0.123 1.000
0.167 0.000* 0.533 0.000* 0.018* 0.162 0.317
Disease duration 0.047 0.351* 0.103 0.345* 0.403* 0.346* 0.214 0.510* 1.000
0.696 0.003* 0.393 0.003* 0.000* 0.003* 0.077 0.000*
Age 0.178* 0.313* 0.107 0.288* 0.080 0.040 0.166 0.710* 0.645* 1.000
0.024* 0.000* 0.176 0.000* 0.313 0.613 0.132 0.000* 0.000*
LFSAP indicates LF component of SAP variability; RR, RR interval; LFRR, LF component of RR variability in nu; HFRR, HF component of RR variability in nu; HbA1c,
glycosylated hemoglobin. In every cell, top row indicates correlation coefficient and bottom row indicates significance. Correlations for HbA1c, creatinine, and disease
duration are computed only for patients.
*Data show significant correlations.
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relaxation,35 might represent a useful adjunct to standard
therapy. This hypothesis, although attractive, requires direct
testing with longer studies on larger populations of patients.
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